Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study
John F.R. Robertson, Teimuraz Gogitidze, Zaza Katashvili, Juan Enrique Bargalló Rocha et autres
gb, ge, mx, nl, sg, pl, es, kr (code pays fourni par la source)